• If this is your first visit, be sure to check out the FAQ & read the forum rules. To view all forums, post or create a new thread, you must be an AAPC Member. If you are a member and have already registered for member area and forum access, you can log in by clicking here. If you've forgotten the password it can be reset on our sign in section by entering your registered Email Address or Username here. To start viewing messages, select the forum that you want to visit from the selection below..

Can I bill PI modifier with a cancer diagnosis?

RaeToll

Networker
Messages
53
Location
Bremen, GA
I received a Medicare claim rejection for CPT code 78816-PIPO (PET/CT whole body) citing inconsistent modifier or required modifier is missing. The primary diagnosis listed on the claim is C61 (malignant neoplasm of prostate). I reviewed the CMS Billing and Coding policy which states, Claims for FDG PET or imaging for oncologic indications for initial treatment strategy must include the “PI” modifier. Claims for FDG PET imaging for oncologic indications for subsequent strategy must include the “PS” modifier.

The physician order reads, 72 years -old Male with high risk prostate cancer, Gleason 9, needing imaging to assess for metastases. The purpose of this scan is for initial anti tumor treatment strategy, initial staging. The imaging findings read, "Ga68 gozetotide PET/CT demonstrates intense abnormal increased PSMA radiotracer uptake in the prostate, consistent with newly diagnosed prostate cancer."
When I run the codes in encoder as billed (78816-PIPO with diagnosis C61) I receive, "Per LCD or NCD guidelines, procedure code 78816 has not met the associated Modifier Code relationship criteria for CMS ID(s) 220.6.17."
When I change the modifier to -PS the claim comes up clean.

Am I not supposed to bill modifier -PI with a cancer diagnosis? I can't find CMS documentation that says either way and I feel the documentation supports the use of modifier PI.
I appreciate anyone that can shed some light on this issue.
 
Top